GB2244709B - Dichloroaniline compound - Google Patents

Dichloroaniline compound

Info

Publication number
GB2244709B
GB2244709B GB9111946A GB9111946A GB2244709B GB 2244709 B GB2244709 B GB 2244709B GB 9111946 A GB9111946 A GB 9111946A GB 9111946 A GB9111946 A GB 9111946A GB 2244709 B GB2244709 B GB 2244709B
Authority
GB
United Kingdom
Prior art keywords
dichloroaniline
compound
dichloroaniline compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9111946A
Other languages
English (en)
Other versions
GB9111946D0 (en
GB2244709A (en
Inventor
Brian David Judkins
Brian Evans
James David Meadows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909012465A external-priority patent/GB9012465D0/en
Priority claimed from GB919104645A external-priority patent/GB9104645D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of GB9111946D0 publication Critical patent/GB9111946D0/en
Publication of GB2244709A publication Critical patent/GB2244709A/en
Application granted granted Critical
Publication of GB2244709B publication Critical patent/GB2244709B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB9111946A 1990-06-05 1991-06-04 Dichloroaniline compound Expired - Fee Related GB2244709B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909012465A GB9012465D0 (en) 1990-06-05 1990-06-05 Chemical compounds
GB919104645A GB9104645D0 (en) 1991-03-05 1991-03-05 Chemical compound

Publications (3)

Publication Number Publication Date
GB9111946D0 GB9111946D0 (en) 1991-07-24
GB2244709A GB2244709A (en) 1991-12-11
GB2244709B true GB2244709B (en) 1994-02-09

Family

ID=26297165

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9111946A Expired - Fee Related GB2244709B (en) 1990-06-05 1991-06-04 Dichloroaniline compound

Country Status (25)

Country Link
EP (1) EP0460924A1 (enExample)
JP (1) JPH05117236A (enExample)
KR (1) KR920000717A (enExample)
AP (1) AP251A (enExample)
AT (1) AT399874B (enExample)
AU (1) AU635424B2 (enExample)
BE (1) BE1005612A5 (enExample)
CA (1) CA2043850A1 (enExample)
CH (1) CH682322A5 (enExample)
DE (1) DE4118293A1 (enExample)
DK (1) DK106991A (enExample)
ES (1) ES2036920B1 (enExample)
FI (1) FI912679A7 (enExample)
FR (1) FR2662691A1 (enExample)
GB (1) GB2244709B (enExample)
GR (1) GR1001309B (enExample)
IE (1) IE911898A1 (enExample)
IL (1) IL98363A0 (enExample)
IT (1) IT1245868B (enExample)
LU (1) LU87945A1 (enExample)
MY (1) MY106672A (enExample)
NL (1) NL9100960A (enExample)
OA (1) OA09501A (enExample)
PT (1) PT97858A (enExample)
SE (1) SE500706C2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
GB0014546D0 (en) 2000-06-14 2000-08-09 Glaxo Group Ltd A novel process
FR2960153B1 (fr) * 2010-05-20 2012-08-17 Centre Nat Rech Scient Nouveaux bras autoreactifs et prodrogues les comprenant

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2187734A (en) * 1986-02-12 1987-09-16 Glaxo Group Ltd Dichloroaniline derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
ATE1899T1 (de) * 1979-06-16 1982-12-15 Beecham Group Plc Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
ES8802416A1 (es) * 1986-04-15 1988-06-01 Glaxo Group Ltd Un procedimiento para la preparacion de derivados de dicloroanilina.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2187734A (en) * 1986-02-12 1987-09-16 Glaxo Group Ltd Dichloroaniline derivatives

Also Published As

Publication number Publication date
AP251A (en) 1993-04-20
SE500706C2 (sv) 1994-08-15
PT97858A (pt) 1992-03-31
CA2043850A1 (en) 1991-12-06
EP0460924A1 (en) 1991-12-11
SE9101687D0 (sv) 1991-06-04
SE9101687L (sv) 1991-12-06
FR2662691B1 (enExample) 1994-04-22
DE4118293A1 (de) 1991-12-12
BE1005612A5 (fr) 1993-11-23
FI912679L (fi) 1991-12-06
FI912679A7 (fi) 1991-12-06
OA09501A (en) 1992-11-15
GB9111946D0 (en) 1991-07-24
FI912679A0 (fi) 1991-06-04
LU87945A1 (fr) 1993-01-15
GR910100242A (en) 1992-08-25
ES2036920A1 (es) 1993-06-01
ITRM910387A1 (it) 1992-12-04
GB2244709A (en) 1991-12-11
AP9100271A0 (en) 1991-07-31
ITRM910387A0 (it) 1991-06-04
IE911898A1 (en) 1991-12-18
DK106991D0 (da) 1991-06-04
CH682322A5 (enExample) 1993-08-31
AU635424B2 (en) 1993-03-18
FR2662691A1 (fr) 1991-12-06
ES2036920B1 (es) 1994-02-16
IL98363A0 (en) 1992-07-15
NL9100960A (nl) 1992-01-02
AT399874B (de) 1995-08-25
MY106672A (en) 1995-07-31
ATA112891A (de) 1994-12-15
DK106991A (da) 1991-12-06
JPH05117236A (ja) 1993-05-14
IT1245868B (it) 1994-10-25
KR920000717A (ko) 1992-01-29
AU7812791A (en) 1991-12-12
GR1001309B (el) 1993-08-31

Similar Documents

Publication Publication Date Title
AP9100313A0 (en) Compounds
GB9001245D0 (en) Compounds
AP9100314A0 (en) Compounds
GB9007965D0 (en) Compounds
GB9007967D0 (en) Compounds
GB9111946D0 (en) Dichloroaniline compound
EP0441598A3 (en) Spiroisoindole compounds
ZA914225B (en) Dichloroaniline compound
GB9027471D0 (en) Novel compound
GB9007738D0 (en) Compounds
GB9012525D0 (en) Compound
GB9015407D0 (en) Compound
GB9018332D0 (en) Compound
GB9025840D0 (en) Compound
GB9025850D0 (en) Compound
GB9002933D0 (en) Compound
GB9021242D0 (en) Compound
PL287543A1 (en) Mineral-bitument compound
GB9003722D0 (en) Novel compound
GB9005674D0 (en) Compounds
GB9001159D0 (en) Compounds
GB9001158D0 (en) Compounds
GB9005673D0 (en) Compounds
GB9004320D0 (en) Compounds
GB9003639D0 (en) Compounds

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19950604